In Q4 2024, Boxer Capital held 1 positions worth $0. They initiated 1 new position and exited 95. Their largest holding was IMA ($0). Portfolio value shrank -100.0% versus the prior quarter.
Frequently asked questions
What stocks did Boxer Capital own in Q4 2024?
Boxer Capital held 1 biotech stocks in their 13F portfolio in Q4 2024. Their top positions include IMA. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Boxer Capital's portfolio worth in Q4 2024?
Boxer Capital's tracked biotech portfolio was worth $0 across 1 positions, with total assets under management of approximately $0.5B. Portfolio values are based on 13F filings with the SEC.
What did Boxer Capital buy in Q4 2024?
Boxer Capital initiated 1 new position in Q4 2024, including IMA. They also increased 0 existing positions.
What did Boxer Capital sell in Q4 2024?
Boxer Capital fully exited 95 positions in Q4 2024, including SANA, SRPT, SWTX, AKRO, ANAB and 90 more. They also trimmed 0 existing positions.
Is Boxer Capital a biotech fund?
San Diego-based biotech specialist investing across the full drug development lifecycle from preclinical through commercial. Takes concentrated positions with deep scientific due diligence, leveraging proximity to the Southern California biotech cluster.
Want AI analysis, insider signals, and catalyst overlays for Boxer Capital?
View latest Boxer Capitalportfolio →